Tritace is a brand-name medication that contains ramipril as its sole active ingredient. Ramipril belongs to the class of drugs known as angiotensin-converting-enzyme (ACE) inhibitors and is used to manage conditions that affect the heart and blood pressure. In Hong Kong, Tritace is available only by prescription and is supplied as a pill in the following strengths: 1.25 mg, 2.5 mg, 5 mg, and 10 mg. The product is regulated by the Hong Kong Department of Health and the Pharmacy and Poisons Board.
Ramipril is a pro-drug that is converted in the liver to the active molecule ramiprilat. Ramiprilat blocks the activity of the angiotensin-converting-enzyme, an enzyme responsible for converting angiotensin I to the potent vasoconstrictor angiotensin II. By reducing angiotensin II levels, Tritace:
The pharmacologic effect begins within 2 hours after a single dose, reaches peak blood-pressure reduction at about 4-6 hours, and can persist for 24 hours, which supports once-daily dosing.
Tritace is approved by the Hong Kong Department of Health for the following indications:
These indications are based on large-scale clinical trials that demonstrated reductions in morbidity and mortality when ramipril was used at therapeutic doses.
Some clinicians prescribe ramipril for conditions that are not listed on the Hong Kong product label but are supported by peer-reviewed research:
These uses are off-label and require careful medical supervision, individualized risk assessment, and regular monitoring of kidney function and electrolytes.
If any of these conditions apply, a healthcare professional should evaluate the risk-benefit balance before prescribing Tritace.
Ramipril is also metabolised by the hepatic enzyme CYP3A4; strong inducers (e.g., rifampicin) can reduce its efficacy, while strong inhibitors may raise plasma concentrations.
Patients should always inform their healthcare provider about all prescription drugs, over-the-counter medicines, herbal supplements, and dietary habits before starting Tritace.
Standard Dosing:
Hypertension: Start with 1.25 mg or 2.5 mg once daily; titrate every 2-4 weeks to the target blood pressure, up to a maximum of 10 mg daily.
Heart Failure or Post-MI: Begin with 2.5 mg once daily; increase to 5 mg after 2 weeks if tolerated, with a possible further increase to 10 mg based on clinical response.
Special Populations:
Elderly: Initiate at the lowest dose (1.25 mg) and increase slowly.
Renal impairment (CrCl < 30 mL/min): Start at 1.25 mg and avoid exceeding 5 mg daily.
Hepatic impairment: No dose adjustment is required for mild disease; severe liver disease warrants careful monitoring.
Administration: Swallow the pill whole with a full glass of water. Do not crush, split, or chew unless the specific formulation states otherwise.
Missed Dose: Take the missed dose as soon as you remember if it is more than 6 hours before the next scheduled dose. Otherwise, skip the missed dose and resume the regular schedule. Do not double the dose.
Overdose: Symptoms may include profound hypotension, dizziness, and renal dysfunction. Seek immediate medical attention; treatment is supportive, and no specific antidote exists.
Discontinuation: Abrupt cessation is generally safe, but patients with heart failure should discuss tapering with a clinician to avoid rebound hypertension.
This article provides educational information about Tritace and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes. A low-salt (sodium-restricted) diet can complement the blood-pressure-lowering effect of Tritace, but it is not a requirement. Continue to follow your clinician’s dietary recommendations for optimal hypertension control.
Carry the medication in its original packaging with a clear label, and keep it in your hand luggage to avoid temperature extremes. If you are flying to a country that restricts ACE inhibitors, bring a copy of the prescription or a letter from your doctor.
In Hong Kong, each strength is typically identified by a distinct imprint code and color shading on the pill. Check the packaging or pharmacy label to confirm the dosage you have received.
Tritace does not contain substances screened for in standard occupational drug tests. However, if your employer requires a specific health-screening panel, disclose your medication list to the testing facility.
Both drugs belong to the same class and lower blood pressure by inhibiting ACE. Ramipril (Tritace) has a longer half-life, allowing once-daily dosing, and has strong evidence for post-myocardial-infarction benefit. Choice of agent depends on individual response, side-effect profile, and prescriber preference.
Yes, as long as the tablets remain intact and are stored at room temperature. Avoid crushing the pills, as this may affect absorption.
ACE inhibitors, including ramipril, are contraindicated during pregnancy because they can cause fetal kidney damage and other serious malformations. Women planning pregnancy should discuss alternative therapies with their physician.
Because ramipril can raise serum potassium, routine potassium supplements are generally not recommended unless a deficiency is documented. Always have potassium levels checked before adding supplements.
St. John’s wort induces CYP3A4 and may reduce the effectiveness of ramipril. Discuss any herbal or over-the-counter products with your healthcare provider before initiating Tritace.
Most patients see a measurable reduction within 2 weeks, with full therapeutic effect often achieved after 4-6 weeks of consistent dosing and titration.
